{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:47:47Z","timestamp":1785880067351,"version":"3.56.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR 10 LABX-0046"],"award-info":[{"award-number":["ANR 10 LABX-0046"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Foundation for Medical Research","doi-asserted-by":"publisher","award":["Equipe labellis\\u00E9e FRM EQU 202203014650"],"award-info":[{"award-number":["Equipe labellis\\u00E9e FRM EQU 202203014650"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.atherosclerosis.2026.120756","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:25:45Z","timestamp":1779679545000},"page":"120756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hepatic amino acid metabolism in liver, cardiovascular, kidney and metabolic diseases"],"prefix":"10.1016","volume":"417","author":[{"given":"Emily","family":"Flam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-1503","authenticated-orcid":false,"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120756_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115074","article-title":"Amino acid metabolism, transport and signalling in the liver revisited","volume":"201","author":"Paulusma","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib2","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"NAFLD Nomenclature consensus group, A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib4","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"On behalf of the American heart Association, cardiovascular-kidney-metabolic health: a presidential advisory from the American heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2025.12.015","article-title":"MASLD, MASH, and the CKM spectrum","author":"Zannad","year":"2026","journal-title":"JACC 0"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib6","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib7","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib8","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.jhep.2023.12.030","article-title":"Almost identical values of various non-invasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia","volume":"80","author":"Nakano","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00726-013-1500-6","article-title":"Functional amino acids in nutrition and health","volume":"45","author":"Wu","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3945\/jn.114.199711","article-title":"L-serine supplementation attenuates alcoholic fatty liver by enhancing homocysteine metabolism in mice and rats","volume":"145","author":"Sim","year":"2015","journal-title":"J Nutr"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib11","first-page":"55","article-title":"Effect of glycine on oxidative stress in rats with alcohol induced liver injury","volume":"59","author":"Senthilkumar","year":"2004","journal-title":"Pharm Times"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1024\/0300-9831\/a000064","article-title":"Protein turnover, ureagenesis and gluconeogenesis","volume":"81","author":"Schutz","year":"2013","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","article-title":"Amino acids: metabolism, functions, and nutrition","volume":"37","author":"Wu","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2003.07.012","article-title":"Amino acid signalling and the integration of metabolism","volume":"313","author":"Meijer","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib16","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.222570","article-title":"Nutrient regulation of mTORC1 at a glance","volume":"132","author":"Condon","year":"2019","journal-title":"J Cell Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib18","doi-asserted-by":"crossref","first-page":"857S","DOI":"10.3945\/ajcn.2009.27462Z","article-title":"Hepatic glutamate metabolism: a tale of 2 hepatocytes","volume":"90","author":"Brosnan","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI109981","article-title":"Branched-chain amino acid nitrogen transfer to alamine in vivo in dogs. Direct isotopic determination with [15N]leucine","volume":"66","author":"Galim","year":"1980","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2337\/diab.31.1.86","article-title":"Branched chain amino acids as a major source of alanine nitrogen in man","volume":"31","author":"Haymond","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib21","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.3390\/ijms25137037","article-title":"Origin and roles of alanine and glutamine in gluconeogenesis in the liver, kidneys, and small intestine under physiological and pathological conditions","volume":"25","author":"Hole\u010dek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib22","unstructured":"J.G. Salway, Metabolism at a glance, fourth ed., Wiley Blackwell, n.d."},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0026-0495(98)90328-6","article-title":"Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans","volume":"47","author":"Stumvoll","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0026-0495(73)90269-2","article-title":"The glucose-alanine cycle","volume":"22","author":"Felig","year":"1973","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/diab.15.3.188","article-title":"Studies on the perfused Rat liver: II. Effect of glucagon on gluconeogenesis","volume":"15","author":"Garcia","year":"1966","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib26","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1016\/S0021-9258(18)63619-1","article-title":"Effects of glucagon on amino acid transport and utilization in the perfused Rat liver","volume":"244","author":"Mallette","year":"1969","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib27","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1172\/JCI106659","article-title":"Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man","volume":"50","author":"Felig","year":"1971","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0028-1096800","article-title":"Effect of insulin and proinsulin on the metabolism of alanine in the Rat liver, horm","volume":"2","author":"Rudorff","year":"1970","journal-title":"Metab Res"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib29","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/db12-1701","article-title":"Histidine augments the suppression of hepatic glucose production by central insulin action","volume":"62","author":"Kimura","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic Fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/CEG.S226130","article-title":"Nonalcoholic fatty liver disease and chronic kidney disease: a review of links and risks","volume":"14","author":"Cheung","year":"2021","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0065-2571(68)90009-5","article-title":"Sequential feedback inhibition and regulation of liver carbohydrate metabolism through control of enzyme activity","volume":"6","author":"Weber","year":"1968","journal-title":"Adv Enzym Regul"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib33","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160381","article-title":"Hepatic glucose utilization in hepatic steatosis and obesity","volume":"36","author":"Keramida","year":"2016","journal-title":"Biosci Rep"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/path.5131","article-title":"Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose\/fatty acid preference under high-fat diet conditions","volume":"246","author":"Liu","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.710420","article-title":"Metabolic changes of hepatocytes in NAFLD","volume":"12","author":"Lu","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib36","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/S0021-9258(18)96571-3","article-title":"Paths of carbon in gluconeogenesis and lipogenesis: III. The role and regulation OF mitochondrial processes INVOLVED IN SUPPLYING PRECURSORS OF phosphoenolpyruvate","volume":"241","author":"Walter","year":"1966","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/39.8.1856459","article-title":"Microquantitative analysis of the intra-acinar profiles of glutamate dehydrogenase in rat liver","volume":"39","author":"Maly","year":"1991","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2156-3-18","article-title":"The human L-threonine 3-dehydrogenase gene is an expressed pseudogene","volume":"3","author":"Edgar","year":"2002","journal-title":"BMC Genet"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib39","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s11064-019-02759-8","article-title":"The effect of 2-Ketobutyrate on mitochondrial substrate-level phosphorylation","volume":"44","author":"Bui","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib40","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0003-9861(74)90337-3","article-title":"Evidence for electrogenic aspartate transport in rat liver mitochondria","volume":"161","author":"LaNoue","year":"1974","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib42","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1016\/S0021-9258(19)81269-3","article-title":"Electrogenic characteristics of the mitochondrial glutamate-aspartate antiporter","volume":"249","author":"LaNoue","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib43","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/iub.2367","article-title":"The malate\u2013aspartate shuttle (borst cycle): how it started and developed into a major metabolic pathway","volume":"72","author":"Borst","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.119054","article-title":"Liver metabolism in human MASLD: a review of recent advancements using human tissue metabolomics","volume":"400","author":"Flam","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic1","volume":"56","author":"Gorden","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2016.06.005","article-title":"Direct assessment of hepatic mitochondrial oxidation and pyruvate cycling in non alcoholic fatty liver disease by 13C magnetic resonance spectroscopy","volume":"24","author":"Petersen","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/bj2050123","article-title":"Purification and properties of acetyl-coa:l-glutamate N-acetyltransferase from human liver","volume":"205","author":"Bachmann","year":"1982","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib48","doi-asserted-by":"crossref","first-page":"2057S","DOI":"10.1093\/jn\/133.6.2057S","article-title":"Amino acids as regulators and components of nonproteinogenic pathways","volume":"133","author":"Meijer","year":"2003","journal-title":"J Nutr"},{"issue":"Pt 1","key":"10.1016\/j.atherosclerosis.2026.120756_bib49","first-page":"1","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.28852","article-title":"Pivotal role of glutamine synthetase in ammonia detoxification","volume":"65","author":"Hakvoort","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/j.1460-2075.1983.tb01464.x","article-title":"Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture","volume":"2","author":"Gebhardt","year":"1983","journal-title":"EMBO J"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/hep.1840090305","article-title":"Localization of ammonia-metabolizing enzymes in human liver: ontogenesis of heterogeneity","volume":"9","author":"Moorman","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib53","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/jn\/128.9.1487","article-title":"Opposite fluxes of glutamine and alanine in the splanchnic area are an efficient mechanism for nitrogen sparing in Rats 1","volume":"128","author":"Lopez","year":"1998","journal-title":"J Nutr"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib54","doi-asserted-by":"crossref","first-page":"G257","DOI":"10.1152\/ajpgi.1997.272.2.G257","article-title":"Glutamine or glutamate release by the liver constitutes a major mechanism for nitrogen salvage","volume":"272","author":"Remesy","year":"1997","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib55","first-page":"2094","article-title":"Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion","volume":"39","author":"Eriksen","year":"2019","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101080","article-title":"Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis","volume":"42","author":"Winther-S\u00f8rensen","year":"2020","journal-title":"Mol Metabol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","article-title":"Urea cycle dysregulation in non-alcoholic fatty liver disease","volume":"69","author":"De Chiara","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0014-5793(01)03123-4","article-title":"Citrulline, a novel compatible solute in drought-tolerant wild watermelon leaves, is an efficient hydroxyl radical scavenger","volume":"508","author":"Akashi","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib59","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/nu10070921","article-title":"l-Citrulline supplementation: impact on cardiometabolic health","volume":"10","author":"Allerton","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib60","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3945\/jn.115.218982","article-title":"Citrulline and nonessential amino acids prevent fructose-induced nonalcoholic Fatty liver disease in rats","volume":"145","author":"Jegatheesan","year":"2015","journal-title":"J Nutr"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.numecd.2018.01.001","article-title":"Amino acid profiles of young adults differ by sex, body mass index and insulin resistance","volume":"28","author":"Guevara-Cruz","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0004563215583360","article-title":"Reference intervals for plasma-free amino acid in a Japanese population","volume":"53","author":"Yamamoto","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched chain amino acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.4057","article-title":"A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance","volume":"22","author":"Jang","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib65","article-title":"\u03b2-aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose\/lipid metabolic disturbance in mice with type 2 diabetes","volume":"6","author":"Shi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib66","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3945\/an.111.000737","article-title":"Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant State","volume":"2","author":"Adams","year":"2011","journal-title":"Adv Nutr"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM196910092811503","article-title":"Plasma amino acid levels and insulin secretion in obesity","volume":"281","author":"Felig","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib68","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1210\/clinem\/dgaa175","article-title":"Plasma BCAA changes in patients with NAFLD are sex dependent","volume":"105","author":"Grzych","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","article-title":"Branched-chain amino acids in cardiovascular disease","volume":"20","author":"McGarrah","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ijo.2014.53","article-title":"Mapping of the circulating metabolome reveals \u03b1-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease","volume":"39","author":"Rodr\u00edguez-Gallego","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","article-title":"Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance","volume":"67","author":"Gaggini","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib73","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","article-title":"Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease","volume":"47","author":"Lake","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159204","article-title":"Altered branched-chain \u03b1-keto acid metabolism is a feature of NAFLD in individuals with severe obesity","volume":"7","author":"Grenier-Larouche","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib75","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1074\/mcp.M116.060145","article-title":"A cell-type-resolved liver proteome","volume":"15","author":"Ding","year":"2016","journal-title":"Mol Cell Proteomics MCP"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib76","doi-asserted-by":"crossref","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib77","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1152\/ajpendo.00351.2003","article-title":"Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor","volume":"286","author":"Davis","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-Carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib79","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/nu14091987","article-title":"Serine metabolism in health and disease and as a conditionally essential amino acid","volume":"14","author":"Hole\u010dek","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib80","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/BJ20061119","article-title":"Inhibition of human betaine\u2013homocysteine methyltransferase expression by S-adenosylmethionine and methylthioadenosine","volume":"401","author":"Ou","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib81","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib82","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib83","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility","volume":"57","author":"Anstee","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib84","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.1840080610","article-title":"Specific loss of the high-molecular-weight form ofS-adenosyl-l-methionine synthetase in human liver cirrhosis","volume":"8","author":"Cabrero","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.1840080113","article-title":"S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis","volume":"8","author":"Duce","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136822","article-title":"Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic Fatty liver disease","volume":"10","author":"Pacana","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib87","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s10620-007-0193-7","article-title":"The transition from Fatty liver to NASH associates with SAMe depletion in db\/db mice Fed a methionine choline-deficient diet","volume":"53","author":"Wortham","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib88","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/ncomms4083","article-title":"Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease","volume":"5","author":"Mardinoglu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib89","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2007-1007167","article-title":"Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine","volume":"18","author":"Ookhtens","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib90","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/antiox10030364","article-title":"Changes in glutathione content in liver diseases: an update","volume":"10","author":"Vairetti","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2019.00089","article-title":"Reactive Oxygen Species (ROS), intimal thickening, and subclinical atherosclerotic disease","volume":"6","author":"Burtenshaw","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413384","article-title":"Mitochondrial oxidative Stress\u2014A causative factor and therapeutic target in many diseases","volume":"22","author":"Kowalczyk","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.627837","article-title":"Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress","volume":"12","author":"Tirichen","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib94","first-page":"1951","article-title":"Restoring glutathione as a therapeutic strategy in chronic kidney disease","volume":"19","author":"Santangelo","year":"2004","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41419-023-05645-y","article-title":"Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis","volume":"14","author":"Tan","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.atherosclerosis.2026.120756_bib96","doi-asserted-by":"crossref","first-page":"MSB167422","DOI":"10.15252\/msb.20167422","article-title":"Personal model assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD","volume":"13","author":"Mardinoglu","year":"2017","journal-title":"Mol Syst Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:07:07Z","timestamp":1785877627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502600122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":96,"alternative-id":["S002191502600122X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120756","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic amino acid metabolism in liver, cardiovascular, kidney and metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120756"}}